Dar Al Dawa Development and Investment Co. Ltd. (ASE: DADI)

Jordan flag Jordan · Delayed Price · Currency is JOD
1.270
+0.010 (0.79%)
At close: Jan 26, 2025
-1.55%
Market Cap 44.45M
Revenue (ttm) 77.95M
Net Income (ttm) 3.35M
Shares Out 35.00M
EPS (ttm) 0.10
PE Ratio 13.27
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 151,623
Average Volume 68,610
Open 1.270
Previous Close 1.260
Day's Range 1.260 - 1.280
52-Week Range 1.210 - 1.420
Beta 0.24
RSI 54.60
Earnings Date Feb 12, 2025

About ASE: DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog... [Read more]

Industry Pharmaceutical Preparations
Founded 1975
Employees 1,067
Stock Exchange Amman Stock Exchange
Ticker Symbol DADI
Full Company Profile

Financial Performance

In 2023, DADI's revenue was 74.88 million, an increase of 24.06% compared to the previous year's 60.36 million. Earnings were 3.16 million, an increase of 59.21%.

Financial Statements

News

There is no news available yet.